Effects of Combined Oral Contraceptives on Women’s Sexual Function, Eje Cafetero, Colombia, 2016-2020

Franklin José Espitia De La Hoz
In: Journal of Sexual Medicine & Research · 2022 · pp. 1–7 · doi:10.47363/jsmr/2022(1)102 · W4225143800
article OA: gold CC0
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-11 ⓘ

This study evaluated the sexual function of 224 women using combined oral contraceptives in Colombia from 2016-2020 via the Female Sexual Function Index.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Introduction: The sexual function of women could be affected by the use of combined oral contraceptives. Objective: To evaluate the sexual function of women users of combined oral contraceptives and to know the adverse events. Materials and methods: Cross-sectional study in 224 women over 18 years of age, sexually active, users of combined oral contraceptives (Estradiol Valerate/ Dienogest: VE₂/DNG, ethinylestradiol/levonorgestrel: EE₂/LNG and ethinylestradiol/drospirenone: EE₂/DSP), who attended three university clinics in the Coffee Region (Colombia); between 2016 and 2020. The Female Sexual Function Index (IFSF) instrument was used. Descriptive statistics were applied.

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (21)

Source provenance

openalex
last seen: 2026-05-14T06:02:11.780192+00:00
License: CC0 · commercial use OK